Changes in other less-investigated pathways suggested additional mechanisms underlying Pompe disease, including negative regulation of Notch (involved in GAA expression86), increased cAMP (involved in glycogen metabolism87), and increased PKC signaling. The gene discussed is GAA; the disease is glycogen storage disease II.